CIAM
DYN icon

Caitong International Asset Management’s Dyne Therapeutics DYN Stock Holding History

Caitong International Asset Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,405
Closed -$189K – 3113
2026
Q1 		$189K Buy
+10,405
New +$179K 0.03% 402
2025
Q3 		– Sell
-1,308
Closed -$12.5K – 2090
2025
Q2 		$12.5K Sell
1,308
-1,784
-58% -$19.6K 0.01% 646
2025
Q1 		$32.3K Buy
3,092
+2,446
+379% +$35K 0.02% 629
2024
Q4 		$15.2K Buy
+646
New +$19.1K 0.01% 869

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Caitong International Asset Management's DYN Position: Q2 2026 in Review

Caitong International Asset Management sold out of Dyne Therapeutics (DYN) in Q2 2026, closing a stake of 10,405 shares — an estimated $189K sold.

Caitong International Asset Management first reported a position in DYN in Q4 2024 and held it in 4 quarters. The position peaked at $189K in Q1 2026. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Caitong International Asset Management reported no remaining Dyne Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 10,405 Dyne Therapeutics shares in Q2 2026, an estimated $189K.
  • Caitong International Asset Management first reported a position in Dyne Therapeutics in Q4 2024 and held it in 4 quarters.
  • Caitong International Asset Management's Dyne Therapeutics position peaked at $189K in Q1 2026.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.